Silexion Therapeutics was listed among pre-market gainers. The article gives no company news explaining the move, so it does not change the view of its business.
A change in Silexion's share price alone says nothing about its sales, treatments, or cash. The article gives no new detail about the company's business, so there is no reason to change how we read it.
Summit Therapeutics was listed among pre-market gainers. The article gives no company news explaining the move, so it does not change the view of its business.
SenesTech was listed among pre-market gainers. The article gives no company news explaining the move, so it does not change the view of its business.
Iovance Biotherapeutics was listed among pre-market gainers. The article gives no company news explaining the move, so it does not change the view of its business.
Senti Biosciences was listed among pre-market gainers. The article gives no company news explaining the move, so it does not change the view of its business.
Crescent Biopharma was listed among pre-market gainers. The article gives no company news explaining the move, so it does not change the view of its business.
Follow Silexion Therapeutics (SLXN) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for SLXN